Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02168049 · ClinicalTrials.gov registry record · NA
Heart and Lung Function Monitoring System
A NA study, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- NA
- Development phase
- 150
- Enrollment target
NCT02168049 is a NA study that has completed, run by University of California, Los Angeles. The registered enrollment target is 150 participants.
The verdict
NCT02168049, a NA study, has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- NA
- Development phase
- 150 participants
- Enrollment target
Study Summary
The investigator goal is to test a new device to see if it can provide continuous and simultaneous monitoring of heart and lung function.
Interventions
- DEVICE Integrated CardioRespiratory System
- DEVICE Transthoracic Echocardiography (TTE)
- DEVICE Electrocardiography
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2014-11 |
| Est. Completion | 2017-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02168049
The ClinicalTrials.gov registry entry for NCT02168049 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Integrated CardioRespiratory System is the first listed.
NCT02168049 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02168049 about?
NCT02168049 is a clinical study titled "Heart and Lung Function Monitoring System". The investigator goal is to test a new device to see if it can provide continuous and simultaneous monitoring of heart and lung function.
What is the current status of trial NCT02168049?
This trial is currently completed. It is a NA study. The enrollment target is 150 participants. The study started on 2014-11. Estimated completion is 2017-09.
What interventions are being tested in trial NCT02168049?
The interventions under investigation include: Integrated CardioRespiratory System (DEVICE), Transthoracic Echocardiography (TTE) (DEVICE), Electrocardiography (DEVICE).
Who is sponsoring clinical trial NCT02168049?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.